As the world adapts to a post-pandemic reality, a new COVID-19 variant emerging in 2025 has sparked renewed concern across global health systems. Despite major advances in vaccination, therapeutics, and public health preparedness, the recent appearance of a novel SARS-CoV-2…
Be the first to know the latest trends in clinical research, real-world case studies, and industry secrets.
ProRelix Research is the rapidly growing Contract/ Clinical Research Organization (CRO) with multi-country service capability supporting phase 1, 2, 3, & 4 clinical trials of Pharma, Biotech, Biopharma, Medical Device, Nutraceutical & Herbal companies to conduct in the USA, India, Europe & South East Asia.